GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients
Phase NA Terminated
42 enrolled 13 charts
EPIK-B3
Phase 3 Terminated
137 enrolled 21 charts
COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation
Terminated
14 enrolled 10 charts
TRANSCENDER
Phase 2 Terminated
2 enrolled 10 charts
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Phase 1 Terminated
115 enrolled 43 charts
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening
Terminated
166 enrolled 5 charts
Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
Phase 1/2 Terminated
8 enrolled 13 charts
Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.
Phase 2 Terminated
13 enrolled 8 charts
Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)
Phase 2 Terminated
1 enrolled
HeartPhone Cancer Survivors Trial 2019
Phase 1/2 Terminated
2 enrolled 6 charts
AMTEC IIT: Phase 2 Multiarm Study in TNBC
Phase 2 Terminated
24 enrolled 16 charts
AMEERA-3
Phase 2 Terminated
367 enrolled 30 charts
Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer
Phase 2 Terminated
27 enrolled 17 charts
Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)
Phase 1/2 Terminated
3 enrolled 8 charts
Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer
Phase 1/2 Terminated
34 enrolled 15 charts
Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer
Phase 1 Terminated
4 enrolled 11 charts
Breast-48
Phase 1 Terminated
13 enrolled 10 charts
INTEGRAL
Phase 2 Terminated
8 enrolled 10 charts
Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer
Phase 2 Terminated
21 enrolled 15 charts
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Phase 1/2 Terminated
61 enrolled 29 charts
neoMono
Phase 2 Terminated
442 enrolled 42 charts
ELPIS
Phase 2 Terminated
5 enrolled 7 charts
Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts
Phase NA Terminated
6 enrolled 9 charts
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer
Phase 2 Terminated
77 enrolled 18 charts
OTT15-04
Phase 4 Terminated
2 enrolled 4 charts
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
Phase 1 Terminated
36 enrolled 7 charts
AMEERA-1
Phase 1/2 Terminated
136 enrolled 60 charts
Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer
Phase 2 Terminated
11 enrolled 13 charts
A Study of PF-06873600 in People With Cancer
Phase 1/2 Terminated
155 enrolled 44 charts
A Study of TAS-120 in Patients With Metastatic Breast Cancer
Phase 2 Terminated
64 enrolled 21 charts
MK-2140-002
Phase 2 Terminated
102 enrolled 36 charts
Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast
Phase NA Terminated
36 enrolled 6 charts
ELEVATE TNBC
Phase 2 Terminated
92 enrolled 27 charts
PAVO
Phase 2 Terminated
22 enrolled 17 charts
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Phase 1/2 Terminated
137 enrolled 31 charts
AXIL95
Phase 3 Terminated
625 enrolled 8 charts
TNBC
Phase 2 Terminated
115 enrolled 31 charts
3-D Super Resolution Ultrasound Microvascular Imaging
Phase 2 Terminated
27 enrolled 12 charts
Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body
Phase 1/2 Terminated
1 enrolled 5 charts
Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer
Phase 1/2 Terminated
2 enrolled 6 charts
CARMEN-BT01
Phase 2 Terminated
50 enrolled 20 charts
Impact of Topical Tranexamic Acid in Breast Reconstruction
Phase 4 Terminated
23 enrolled 9 charts
WI223281
Phase 2 Terminated
17 enrolled 9 charts
AMEERA-4
Phase 2 Terminated
105 enrolled 16 charts
Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer
Phase 2 Terminated
20 enrolled 13 charts
AMEERA-6
Phase 3 Terminated
3 enrolled 3 charts
AMEERA-5
Phase 3 Terminated
1,068 enrolled 21 charts
Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC
Phase 1/2 Terminated
10 enrolled 15 charts
Fluorescence Imaging of Carcinoma During Breast Conserving Surgery
Phase 3 Terminated
57 enrolled 8 charts
Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD
Phase 2 Terminated
17 enrolled 16 charts